Career history of Christopher Bryant
Former positions of Christopher Bryant
Companies | Position | Start | End |
---|---|---|---|
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 2009-06-30 | 2013-11-30 |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Chief Tech/Sci/R&D Officer | 2011-03-02 | - |
ProMetic BioTherapeutics, Inc.
ProMetic BioTherapeutics, Inc. BiotechnologyHealth Technology Part of KEDRION HOLDING S.P.A., ProMetic BioTherapeutics, Inc. is a company that manufactures plasma protein fractionation products. The company is based in Rockville, MD. ProMetic BioTherapeutics was acquired by Kedrion Biopharma, Inc. on October 18, 2021. | Chief Operating Officer | - | - |
Training of Christopher Bryant
University of California San Diego | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Health Technology |
ProMetic BioTherapeutics, Inc.
ProMetic BioTherapeutics, Inc. BiotechnologyHealth Technology Part of KEDRION HOLDING S.P.A., ProMetic BioTherapeutics, Inc. is a company that manufactures plasma protein fractionation products. The company is based in Rockville, MD. ProMetic BioTherapeutics was acquired by Kedrion Biopharma, Inc. on October 18, 2021. | Health Technology |
- Stock Market
- Insiders
- Christopher Bryant
- Experience